47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
68.20.Z - Rental and management of own or leased real estate
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | -0,3 | -0,1 | 67 |
EBITDA | 0 | -0,2 | -0 | 91,1 |
Short time liabilities | 1,1 | 1,5 | 1,5 | 0,9 |
Equity capital | -0,4 | -0,7 | -0,8 | -14,4 |
Operating profit (EBIT) | 0 | -0,2 | -0 | 84,1 |
Assets | 0,8 | 0,8 | 0,8 | -6,8 |
Net profit (loss) | 0 | -0,3 | -0,1 | 67 |
Cash | 0,1 | 0,2 | 0,1 | -33,4 |
Net income from sale | 3,8 | 4,1 | 4,8 | 14,9 |
Liabilities and provisions for liabilities | 1,2 | 1,5 | 1,5 | 2,5 |
Working assets | 0,7 | 0,8 | 0,7 | -6,7 |
Depreciation | 0 | 0 | 0 | -20,8 |
% | % | % | p.p. | |
Profitability of capital | -1,3 | 43,8 | 12,6 | -31,2 |
Equity capital to total assets | -47,6 | -78 | -95,7 | -17,7 |
Gross profit margin | 0,1 | -7 | -2 | 5 |
EBITDA Margin | 1,1 | -4,1 | -0,3 | 3,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 109 | 128 | 113 | -15 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane